|
|
|
|
|
The Niche
|
Stem Cell & Regenerative Med Newsletter
|
|
|
|
|
|
Weekly reads: CRISPR'd marsupial, outpatient recovery post stem cell transplants, Parkinson's, pubs
|
|
|
|
This edition of The Niche weekly reads has a bit more good news than usual including on stem cell transplants. It's nice to see positive developments like some recipients of hematopoietic stem cell transplants being able to stay at home afterwards. Also, a reminder. You have until July 31 to enter our stem cell video contest to try to win …
|
|
|
|
|
|
|
|
Translating the FDA's Q&A on end of stem cell grace period
|
|
|
|
The FDA grace period for stem cell clinics and others using regenerative medicine products like stem cells is over. It appears the agency is serious about enforcement moving forward. They have released several statements about the end of what they call the "enforcement discretion" period, which just means in English a grace period for marketers of cellular therapies is over. …
|
|
|
|
|
|
|
|
Stem cell therapy: the good, the bad, & the muddy waters
|
|
|
|
How can you tell who to trust in the world of stem cell therapy? What information can a patient trust? Once upon a time about a dozen years ago it seemed a much simpler question. There were universities and biotech companies doing legit research as well as clinical trials, and there were physicians doing bone marrow transplant type work. Back …
|
|
|
|
|
|
